Correlation Between Beam Therapeutics and Allogene Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Allogene Therapeutics, you can compare the effects of market volatilities on Beam Therapeutics and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Allogene Therapeutics.

Diversification Opportunities for Beam Therapeutics and Allogene Therapeutics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Beam and Allogene is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Allogene Therapeutics go up and down completely randomly.

Pair Corralation between Beam Therapeutics and Allogene Therapeutics

Given the investment horizon of 90 days Beam Therapeutics is expected to generate 0.94 times more return on investment than Allogene Therapeutics. However, Beam Therapeutics is 1.06 times less risky than Allogene Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  2,209  in Beam Therapeutics on August 25, 2024 and sell it today you would earn a total of  296.00  from holding Beam Therapeutics or generate 13.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Beam Therapeutics  vs.  Allogene Therapeutics

 Performance 
       Timeline  
Beam Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Beam Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Beam Therapeutics is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Allogene Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allogene Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Beam Therapeutics and Allogene Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beam Therapeutics and Allogene Therapeutics

The main advantage of trading using opposite Beam Therapeutics and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.
The idea behind Beam Therapeutics and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes